Reveal Earnings Forecast for Apple, Gilead Sciences, Alibaba, Twitter, BlackBerry, and Sirius XM

PHOENIX, January 5, 2015 /PRNewswire/ — EarningForecast.com has issued earnings forecast research with special focus on financial performance of the following stocks: Apple (NASDAQ:AAPL), Gilead Sciences (NASDAQ:GILD), Alibaba (NYSE:BABA), Twitter (NYSE:TWTR), BlackBerry (NASDAQ:BBRY), and Sirius XM (NASDAQ:SIRI).

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

Apple Inc. (NASDAQ:AAPL): The share of Apple (NASDAQ:AAPL) began the trading session with a price of US$111.39. When day-trade ended, the stock price lost 0.95% to US$109.33 by the end of last trading session with 53.20 million shares exchanged hands, compared to daily average volume of 48.08 million. Apple announced its wearable device called Apple Watch in October 2014, but has said it won’t launch it until early this year. Fred Wilson of Union Square Venture said in a blog post that the Apple Watch, "will not be the homerun product that iPod, iPhone, and iPad have been." The company has improved earnings per share by 20.3% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, the idevice maker increased its bottom line by earning US$6.43 versus US$5.66 in the prior year. The industry of Electronic Equipment dropped about 1.24%, the competitor BlackBerry Limited lost about 1.46% to the price of US$10.82. Do you think Apple will go on? Do you think now is a good time to buy the stock? Investors could check AAPL earnings forecast report here.

Read Full Report: http://www.earningforecast.com/PR/010515A/AAPL/Apple.pdf

Gilead Sciences, Inc. (NASDAQ:GILD): The share of Gilead Sciences (NASDAQ:GILD) began the trading session with a price of US$95.14. When day-trade ended, the stock price earned 0.69% to US$94.91 by the end of last trading session with 12.34 million shares exchanged hands, compared to daily average volume of 18.95 million. The biotech company announced it had expanded an agreement with Janssen R&D Ireland last Monday. The deal is for the development and commercialization of a new once-daily single tablet regimen that contains Gilead’s tenofovir alafenamide (TAF) and emtricitabine, as well as Janssen’s rilpivirine. The two parties reached the original agreement in 2009 to develop and market Complera, marketed as Eviplera in the European Union. The companys very impressive revenue growth greatly exceeded the industry average of 39.0%. Since the same quarter one year prior, revenues leaped by 117.1%. Growth in the company’s revenue appears to have helped boost the earnings per share. The industry of Biotechnology lost about 0.01%, the competitor GlaxoSmithKline plc dropped about 0.87% to the price of US$42.37. Do you think Gilead Sciences will go on? Do you think now is a good time to buy the stock? Investors could check GILD earnings forecast report here.

Read Full Report: http://www.earningforecast.com/PR/010515A/GILD/GileadSciences.pdf

Alibaba Group Holding Ltd (NYSE:BABA): The share of Alibaba (NYSE:BABA) began the trading session with a price of US$104.24. When day-trade ended, the stock price lost 0.33% to US$103.60 by the end of last trading session with 12.30 million shares exchanged hands, compared to daily average volume of 19.05 million. Ant Financial Services Group, Alibaba’s e-commerce affiliate, reportedly announced last week that shoppers on Alibaba’s Tmall and Taobao e-commerce sites can now take out month-to-month loans of up to $4,800 using a new payment option called Huabei, or Just Spend. Credit services in China are small but on the rise as the country’s younger consumers are increasingly willing to take on debt. The industry of Specialty Retail, Other slid about 0.24%, the competitor eBay Inc. rose about 0.16% to the price of US$56.21. Do you think Alibaba will go on? Do you think now is a good time to buy the stock? Investors could check BABA earnings forecast report here.

Read Full Report: http://www.earningforecast.com/PR/010515A/BABA/Alibaba.pdf

Today EarningForecast.com also observed abnormal trade volume for the following companies; Check out the consensus earnings forecast reports below:

Twitter Inc (NYSE:TWTR):
Read Full Report: http://www.earningforecast.com/PR/010515A/TWTR/Twitter.pdf

BlackBerry Ltd (NASDAQ:BBRY):
Read Full Report: http://www.earningforecast.com/PR/010515A/BBRY/BlackBerry.pdf

Sirius XM Holdings Inc. (NASDAQ:SIRI):
Read Full Report: http://www.earningforecast.com/PR/010515A/SIRI/SiriusXM.pdf

About EarningForecast.com:

EarningForecast.com focuses on tracking and monitoring company Earnings Data for top market movers in US stocks market. EarningForecast.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:

Please visit: EarningForecast.com/disclaimers/index.php for details.

Logo: http://photos.prnewswire.com/prnh/20130725/HK53184LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/reveal-earnings-forecast-for-apple-gilead-sciences-alibaba-twitter-blackberry-and-sirius-xm-300015420.html